These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 34260036)

  • 1. Clinical trial on the effects of oral magnesium supplementation in stable-phase COPD patients.
    Zanforlini BM; Ceolin C; Trevisan C; Alessi A; Seccia DM; Noale M; Maggi S; Guarnieri G; Vianello A; Sergi G
    Aging Clin Exp Res; 2022 Jan; 34(1):167-174. PubMed ID: 34260036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of daily vitamin D supplementation on respiratory muscle strength and physical performance in vitamin D-deficient COPD patients: a pilot trial.
    Rafiq R; Prins HJ; Boersma WG; Daniels JM; den Heijer M; Lips P; de Jongh RT
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2583-2592. PubMed ID: 28894361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Creatine supplementation and physical training in patients with COPD: a double blind, placebo-controlled study.
    Faager G; Söderlund K; Sköld CM; Rundgren S; Tollbäck A; Jakobsson P
    Int J Chron Obstruct Pulmon Dis; 2006; 1(4):445-53. PubMed ID: 18044100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of low-dose theophylline for the management of biomass-associated COPD (LODOT-BCOPD): study protocol for a randomized controlled trial.
    Siddharthan T; Pollard SL; Jackson P; Robertson NM; Wosu AC; Rahman N; Padalkar R; Sekitoleko I; Namazzi E; Alupo P; Hurst JR; Kalyesubula R; Dowdy D; Wise R; Barnes PJ; Checkley W; Kirenga B
    Trials; 2021 Mar; 22(1):213. PubMed ID: 33726828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of exacerbations in patients with COPD and vitamin D deficiency through vitamin D supplementation (PRECOVID): a study protocol.
    Rafiq R; Aleva FE; Schrumpf JA; Heijdra YF; Taube C; Daniels JM; Lips P; Bet PM; Hiemstra PS; van der Ven AJ; den Heijer M; de Jongh RT
    BMC Pulm Med; 2015 Sep; 15():106. PubMed ID: 26399451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease.
    Chong J; Leung B; Poole P
    Cochrane Database Syst Rev; 2017 Sep; 9(9):CD002309. PubMed ID: 28922692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Umeclidinium bromide versus placebo for people with chronic obstructive pulmonary disease (COPD).
    Ni H; Htet A; Moe S
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD011897. PubMed ID: 28631387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nutritional supplementation for stable chronic obstructive pulmonary disease.
    Ferreira IM; Brooks D; White J; Goldstein R
    Cochrane Database Syst Rev; 2012 Dec; 12():CD000998. PubMed ID: 23235577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Lifestyle Physical Activity Intervention for Patients with Chronic Obstructive Pulmonary Disease. A Randomized Controlled Trial.
    Coultas DB; Jackson BE; Russo R; Peoples J; Sloan J; Singh KP; Ashmore J; Blair SN; Uhm M; Bae S
    Ann Am Thorac Soc; 2016 May; 13(5):617-26. PubMed ID: 26785249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease.
    Chong J; Leung B; Poole P
    Cochrane Database Syst Rev; 2013 Nov; (11):CD002309. PubMed ID: 24190161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benralizumab for chronic obstructive pulmonary disease and sputum eosinophilia: a randomised, double-blind, placebo-controlled, phase 2a study.
    Brightling CE; Bleecker ER; Panettieri RA; Bafadhel M; She D; Ward CK; Xu X; Birrell C; van der Merwe R
    Lancet Respir Med; 2014 Nov; 2(11):891-901. PubMed ID: 25208464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized controlled trial for prevention of acute exacerbation of stable chronic obstructive pulmonary disease with acupoint application of traditional Chinese medicine: Study protocol clinical trial (SPIRIT Compliant).
    Zhang C; Yang H; Gan W; Chen J; Yang Y; Xiao W; Long K; Chen K; Huang Q; Gao P
    Medicine (Baltimore); 2020 Mar; 99(10):e19396. PubMed ID: 32150085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of protein supplementation on quality of life, physical function, and muscle strength in patients with chronic obstructive pulmonary disease.
    Ahnfeldt-Mollerup P; Hey H; Johansen C; Kristensen S; Brix Lindskov J; Jensahnfeldt-Mollerupen C
    Eur J Phys Rehabil Med; 2015 Aug; 51(4):447-56. PubMed ID: 25426541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CXCR2 antagonist for patients with chronic obstructive pulmonary disease with chronic mucus hypersecretion: a phase 2b trial.
    Lazaar AL; Miller BE; Donald AC; Keeley T; Ambery C; Russell J; Watz H; Tal-Singer R;
    Respir Res; 2020 Jun; 21(1):149. PubMed ID: 32532258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose oral theophylline combined with inhaled corticosteroids for people with chronic obstructive pulmonary disease and high risk of exacerbations: a RCT.
    Devereux G; Cotton S; Fielding S; McMeekin N; Barnes PJ; Briggs A; Burns G; Chaudhuri R; Chrystyn H; Davies L; Soyza A; Gompertz S; Haughney J; Innes K; Kaniewska J; Lee A; Morice A; Norrie J; Sullivan A; Wilson A; Price D
    Health Technol Assess; 2019 Jul; 23(37):1-146. PubMed ID: 31343402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-acting beta2-agonists for chronic obstructive pulmonary disease.
    Kew KM; Mavergames C; Walters JA
    Cochrane Database Syst Rev; 2013 Oct; (10):CD010177. PubMed ID: 24127118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Singing for adults with chronic obstructive pulmonary disease (COPD).
    McNamara RJ; Epsley C; Coren E; McKeough ZJ
    Cochrane Database Syst Rev; 2017 Dec; 12(12):CD012296. PubMed ID: 29253921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial.
    Decramer M; Celli B; Kesten S; Lystig T; Mehra S; Tashkin DP;
    Lancet; 2009 Oct; 374(9696):1171-8. PubMed ID: 19716598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tiotropium versus placebo for chronic obstructive pulmonary disease.
    Karner C; Chong J; Poole P
    Cochrane Database Syst Rev; 2012 Jul; (7):CD009285. PubMed ID: 22786525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fortified whey beverage for improving muscle mass in chronic obstructive pulmonary disease: a single-blind, randomized clinical trial.
    Ahmadi A; Eftekhari MH; Mazloom Z; Masoompour M; Fararooei M; Eskandari MH; Mehrabi S; Bedeltavana A; Famouri M; Zare M; Nasimi N; Sohrabi Z
    Respir Res; 2020 Aug; 21(1):216. PubMed ID: 32807165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.